KZR · Kezar Life Sciences, Inc.
$7.29
+0.00 (+0.00%)
At close · May 11
Market Cap
$53.86M
Shares
7.39M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-05-11 | 2026-05-08 | |
| 10-Q | 2026-05-11 | 2026-03-31 | |
| 10-K/A | 2026-04-30 | 2025-12-31 | |
| 8-K | 2026-04-03 | 2026-04-01 | |
| 8-K | 2026-03-30 | — | |
| 10-K | 2026-03-27 | 2025-12-31 | |
| 8-K | 2026-03-12 | 2026-03-06 | |
| 10-Q | 2025-11-12 | 2025-09-30 | |
| 8-K | 2025-11-12 | — | |
| 8-K | 2025-11-07 | 2025-11-06 | |
| 8-K | 2025-10-22 | 2025-10-20 | |
| 8-K | 2025-10-16 | — | |
| 10-Q | 2025-08-13 | 2025-06-30 | |
| 8-K | 2025-08-13 | — | |
| 8-K | 2025-06-23 | 2025-06-17 | |
| 8-K | 2025-05-13 | — | |
| 10-Q | 2025-05-13 | 2025-03-31 | |
| DEF 14A | 2025-04-25 | 2025-06-17 | |
| 8-K | 2025-04-01 | 2025-03-27 | |
| 8-K | 2025-03-25 | — | |
| 10-K | 2025-03-25 | 2024-12-31 | |
| 8-K | 2025-02-27 | — | |
| 8-K | 2025-01-10 | — | |
| 8-K | 2024-12-03 | — | |
| 8-K | 2024-11-14 | 2024-11-13 | |
| 8-K | 2024-11-12 | — | |
| 10-Q | 2024-11-12 | 2024-09-30 | |
| 8-K | 2024-10-28 | — | |
| 8-K | 2024-10-17 | — | |
| 8-K | 2024-10-10 | — | |
| 8-K | 2024-10-04 | — | |
| 8-K | 2024-09-30 | — | |
| 10-Q | 2024-08-13 | 2024-06-30 | |
| 8-K | 2024-08-13 | — | |
| 8-K | 2024-06-21 | 2024-06-18 | |
| 8-K | 2024-06-04 | 2024-05-31 | |
| 10-Q | 2024-05-09 | 2024-03-31 | |
| 8-K | 2024-05-09 | — | |
| DEF 14A | 2024-04-26 | — | |
| 10-K | 2024-03-14 | 2023-12-31 | |
| 8-K | 2024-03-14 | — | |
| 8-K | 2024-01-08 | — | |
| 8-K | 2023-12-04 | 2023-12-01 | |
| 8-K | 2023-11-13 | — | |
| 10-Q | 2023-11-13 | 2023-09-30 | |
| 8-K | 2023-10-27 | 2023-10-23 | |
| 8-K | 2023-10-03 | 2023-09-30 | |
| 8-K | 2023-09-21 | 2023-09-20 | |
| 8-K | 2023-08-14 | 2023-08-11 | |
| 10-Q | 2023-08-10 | 2023-06-30 |
Showing 1–50 of 111 filings